NewEdge Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $83 | Hold |
|
|||||
|
2024
Q4 | $83 | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $212 | Hold |
|
|||||
|
2023
Q2 | $211 | Sell |
|
|||||
|
2023
Q1 | $34.3K | Sell |
|
|||||
|
2022
Q4 | $96 | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $187K | Sell |
|
|||||
|
2021
Q4 | $175K | Sell |
|
|||||
|
2021
Q3 | $205K | Buy |
|
|||||
|
2021
Q2 | $194K | Sell |
|
|||||
|
2021
Q1 | $126K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $82K | Buy |
|